VENTX (HPX42B) as A Drug Target for Various Diseases (G27287)

Target Name: VENTX

NCBI ID: G27287

VENTX

VENTX (HPX42B) as A Drug Target for Various Diseases

VENTX (HPX42B) is a drug target (or biomarker) that is being studied for its potential therapeutic effects in the treatment of various diseases, including cancer. It is a protein that is expressed in various tissues and organs, including the brain, lungs, heart, kidneys, and gastrointestinal tract.

VENTX (HPX42B) has been shown to play a role in a number of important biological processes, including cell signaling, inflammation, and fibrosis. It is a key regulator of the TGF-β pathway, which is a well-known process that is involved in the development and maintenance of tissues and organs.

Research has also shown that VENTX (HPX42B) is involved in the regulation of cell proliferation, differentiation, and survival. It has been shown to inhibit the activity of the oncogene transforming growth factor (TGF-β), which is a key regulator of cell growth and differentiation.

In addition to its role in cell signaling and regulation, VENTX (HPX42B) has also been shown to be involved in the regulation of inflammation. It has been shown to play a role in the regulation of immune cell function and the development of inflammatory diseases.

VENTX (HPX42B) may also have potential as a biomarker for certain diseases. It can be used as a target for diagnostic tests, such as peptide-based assays, to diagnose and monitor the progression of certain diseases.

In conclusion, VENTX (HPX42B) is a promising drug target (or biomarker) with potential for the treatment of a variety of diseases. Further research is needed to fully understand its role and to develop safe and effective treatments.

Protein Name: VENT Homeobox

Functions: May be involved in ventralization

The "VENTX Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VENTX comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets